The Lymphoma Research Foundation has published a report on Mantle Cell Lymphoma, highlighting the disease's rarity and the need for further research. The report, based on the 2009 MCL Scientific Workshop, aims to accelerate advances in MCL treatment and improve patient outcomes.
The Lymphoma Research Foundation has awarded grants of $300,000 and $200,000 to Drs. David Frank and Thomas Kipps for their research on Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL). The grants aim to develop new treatments for patients with refractory disease.
Dr. Kai Fu receives $300K Clinical Investigator Career Development Award for mantle cell lymphoma research, focusing on miR-17~92 expression and its correlation with patient survival. The funding aims to support a pre-clinical study to determine the effectiveness of suppressing miR-17~92 in improving chemotherapy outcomes.
The Sixth Annual Mantle Cell Lymphoma Consortium Scientific Workshop brought together experts to discuss key issues in MCL research, including biomarkers, chemoimmunotherapy, and novel therapeutic strategies. The report highlights the progress made in understanding this rare disease and its treatment options.